By now you have probably heard about GLP-1 medications. Ozempic. Wegovy. Mounjaro. They are everywhere — in the news, in your social media feed, in conversations at the doctor's office. And the conversation almost always centers on one thing: weight loss.

But here is what is not making the headlines nearly enough.

For women over 60, the benefits of GLP-1 medications extend far beyond the scale. In fact, some of the most significant effects have nothing to do with weight at all. And if you have been dismissing these medications as "just a diet drug" — or if you have been curious but felt like they were not for you because weight loss is not your primary concern — I want you to keep reading.

Because this conversation is bigger than that.

GLP-1 stands for glucagon-like peptide-1. It is a hormone your body naturally produces in response to eating. It signals your pancreas to release insulin, tells your liver to slow down glucose production, and sends messages to your brain that you are full.

GLP-1 receptor agonists — the medications — mimic and amplify this hormone. They were originally developed to treat type 2 diabetes. The weight loss effects were discovered later, almost as a side effect.

But as researchers have continued studying these medications, they have found something remarkable: GLP-1 receptors exist throughout the body. In the heart. In the brain. In the kidneys. In the immune system. Which means the effects of these medications ripple out in ways that scientists are still working to fully understand.

For women over 60, many of those ripple effects are genuinely significant.

This is perhaps the most well-documented benefit beyond weight loss, and it is one that every woman over 60 should know about.

Cardiovascular disease is the leading cause of death in women — and the risk increases substantially after menopause. The drop in estrogen that comes with menopause affects cholesterol levels, blood pressure, and the flexibility of blood vessels. By the time a woman reaches her 60s, her cardiovascular risk profile looks very different than it did in her 40s.

GLP-1 medications have been shown in multiple large clinical trials to reduce the risk of major cardiovascular events — heart attack, stroke, and cardiovascular death — in people with existing heart disease or high cardiovascular risk. The LEADER trial, the SUSTAIN-6 trial, and the SELECT trial have all produced significant findings in this area.

And importantly, researchers believe these cardiovascular benefits are not entirely explained by weight loss. The medications appear to have direct protective effects on the heart and blood vessels — reducing inflammation in arterial walls, improving how the heart muscle functions, and lowering blood pressure.

For a woman in her 60s who has been told she is at elevated cardiovascular risk, this is not a small thing.

This is the one that surprises people most, and it is the one I find most compelling for women in this chapter of life.

GLP-1 receptors are present throughout the brain, including in regions associated with memory, learning, and executive function. Researchers have been studying the potential neuroprotective effects of GLP-1 medications for years, and the early findings are genuinely exciting.

Several studies have shown associations between GLP-1 medication use and reduced risk of cognitive decline. There is ongoing research into whether these medications may have a protective effect against Alzheimer's disease and other forms of dementia. The mechanisms being studied include reduced neuroinflammation, improved insulin signaling in the brain (the brain is highly insulin-dependent), and protection against the kind of cellular damage that accumulates over time.

Beyond the long-term research, many women report something more immediate: a reduction in what they describe as brain fog. Clearer thinking. Better focus. More mental energy.

Some of this may be related to improved blood sugar regulation — the brain runs on glucose, and when blood sugar is more stable, cognitive function often improves. Some of it may be the direct effects of GLP-1 on brain tissue. The research is still evolving.

But for women over 60 who have been quietly worried about their cognitive health — and many of us are — this is a thread worth following.

Chronic low-grade inflammation is one of the most significant drivers of aging-related disease. It contributes to cardiovascular disease, cognitive decline, joint pain, metabolic dysfunction, and a host of other conditions that become more common as we get older.

After menopause, inflammation tends to increase. Estrogen had anti-inflammatory properties, and its decline removes a protective effect that many women did not even know they had.

GLP-1 medications appear to have meaningful anti-inflammatory effects. Studies have shown reductions in inflammatory markers — including C-reactive protein and interleukin-6 — in people taking these medications. These effects appear to be at least partially independent of weight loss.

For women over 60 dealing with joint pain, fatigue, or other symptoms that may be inflammation-related, this is worth a conversation with your doctor.

Even if you do not have diabetes or prediabetes, blood sugar regulation becomes more challenging as we age. Insulin sensitivity tends to decline after menopause. The result is more pronounced blood sugar swings — the kind that leave you feeling energized one hour and exhausted the next, craving sugar in the afternoon, waking at 3 AM with your mind racing.

GLP-1 medications improve insulin sensitivity and smooth out those blood sugar fluctuations. Many women report that this alone — the steadier energy, the reduced cravings, the more consistent mood — is one of the most noticeable quality-of-life improvements they experience.

This is not just about diabetes prevention, though that matters too. It is about how you feel day to day. The energy you have to show up for your life.

This one does not get nearly enough attention.

Kidney function naturally declines with age, and women with diabetes, high blood pressure, or cardiovascular disease are at elevated risk for chronic kidney disease. GLP-1 medications have been shown to slow the progression of kidney disease and reduce the risk of kidney-related complications.

The FLOW trial, published in 2024, showed that semaglutide (the active ingredient in Ozempic and Wegovy) significantly reduced the risk of major kidney disease events in people with type 2 diabetes and chronic kidney disease. The findings were significant enough that the trial was stopped early.

For women over 60 who have been told their kidney function is something to watch, this is a meaningful development.

Poor sleep is one of the most common complaints among women in their 60s. Hormonal changes, increased rates of sleep apnea, anxiety, and the general disruptions that come with aging all contribute to sleep that is lighter, more fragmented, and less restorative than it used to be.

GLP-1 medications have been associated with improvements in sleep quality, and there is a specific mechanism that researchers find particularly interesting: these medications reduce the severity of obstructive sleep apnea. A 2024 study published in the New England Journal of Medicine found that semaglutide reduced the severity of sleep apnea by approximately 20 apnea events per hour — a clinically meaningful reduction.

Better sleep is not a small quality-of-life improvement. Sleep affects everything — mood, cognitive function, immune health, cardiovascular health, metabolic function. For women over 60 who have been struggling with sleep for years, this is significant.

I want to be clear about something: I am not telling you to go get a GLP-1 prescription. That is a conversation between you and your doctor, and it involves your full medical history, your current health status, your other medications, and your personal goals.

What I am telling you is that if you have been dismissing these medications as "not for you" because you are not primarily focused on weight loss — or if you have been curious but felt like you needed a better reason than the number on the scale — there are reasons. Real, medically significant reasons that are particularly relevant to women in their 60s.

The research is evolving quickly. What we know today is already substantial. What we will know in five years will be more.

You deserve to have access to that information. You deserve to walk into your doctor's office with real questions, not just the ones the headlines have given you. You deserve to make decisions about your health from a place of knowledge rather than assumption.

Here is the thing I keep coming back to, as someone who works with women navigating this chapter of life.

So many women over 60 have spent decades putting their health last. Taking care of everyone else. Dismissing their own symptoms as "just aging." Accepting a level of fatigue, brain fog, joint pain, and poor sleep as the inevitable price of getting older.

It is not inevitable. Not all of it.

Some of what we have accepted as the cost of aging is actually the cost of inflammation, of blood sugar dysregulation, of cardiovascular risk that was never addressed, of sleep deprivation that has been going on for years. And some of those things are addressable.

GLP-1 medications are one tool. Not the only tool. Not the right tool for everyone. But a tool that is showing real promise for addressing some of the underlying mechanisms that drive the conditions that steal quality of life from women in their 60s and beyond.

You are not too old for this conversation. You are exactly the right age for it.

I would be doing you a disservice if I did not acknowledge this: for many women, the conversation about GLP-1 medications is emotionally loaded.

There is the diet culture baggage — the sense that taking a medication for weight-related reasons means you have failed at something. There is the fear of being judged. There is the internalized message that you should be able to manage your health through willpower alone.

I want to name all of that and set it aside.

Your health is not a moral issue. The choices you make about your body — including whether to explore medications that might genuinely improve your quality of life and reduce your disease risk — are medical decisions, not character judgments.

You are allowed to want to feel better. You are allowed to be curious about tools that might help. You are allowed to have a conversation with your doctor without apologizing for it.

That is not weakness. That is taking yourself seriously. And after 60 years of living, you have earned the right to do exactly that.

This post is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Karen Gonyea is an ICF-certified life coach, not a medical professional.

If you are navigating the emotional and identity questions that come with this chapter of life, explore the courses and coaching inside The Good Girl Box.